NAVELBINE Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Navelbine, and when can generic versions of Navelbine launch?

Navelbine is a drug marketed by Pierre Fabre and is included in one NDA.

The generic ingredient in NAVELBINE is vinorelbine tartrate. There are fifteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the vinorelbine tartrate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Navelbine

A generic version of NAVELBINE was approved as vinorelbine tartrate by HIKMA on June 10^th, 2003.

Try a Trial

Summary for NAVELBINE

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	45
Clinical Trials:	134
Patent Applications:	4,902
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for NAVELBINE
What excipients (inactive ingredients) are in NAVELBINE?	NAVELBINE excipients list
DailyMed Link:	NAVELBINE at DailyMed

Drug patent expirations by year for NAVELBINE

Recent Clinical Trials for NAVELBINE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Seagen Inc.	Phase 2
Yonsei University	Phase 2
Children's Oncology Group	Phase 3

See all NAVELBINE clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for NAVELBINE

L01CA	Vinca alkaloids and analogues
L01C	PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
L01	ANTINEOPLASTIC AGENTS
L	Antineoplastic and immunomodulating agents

US Patents and Regulatory Information for NAVELBINE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pierre Fabre	NAVELBINE	vinorelbine tartrate	INJECTABLE;INJECTION	020388-001	Dec 23, 1994		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for NAVELBINE

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pierre Fabre	NAVELBINE	vinorelbine tartrate	INJECTABLE;INJECTION	020388-001	Dec 23, 1994	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for NAVELBINE

See the table below for patents covering NAVELBINE around the world.

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
Japan	S6332795		⤷ Try a Trial
France	2434171		⤷ Try a Trial
Netherlands	990027		⤷ Try a Trial
Japan	S5531096	NOVEL COMPOUND BISSINDOLINE DERIVATIVE ACTIVE AS DRUG AND ITS MANUFACTURE	⤷ Try a Trial
France	2434172		⤷ Try a Trial
Germany	2966049		⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Supplementary Protection Certificates for NAVELBINE

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0010458	SPC/GB96/037	United Kingdom	⤷ Try a Trial	SPC/GB96/037, EXPIRES: 20040410
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Summary for NAVELBINE

Recent Clinical Trials for NAVELBINE

Anatomical Therapeutic Chemical (ATC) Classes for NAVELBINE

Make Better Decisions: Try a trial or see plans & pricing